Domů › Rakovina prsu › Virginia › Richmond
Klinické studie Rakovina prsu v Richmond, VA
26 studií pro Rakovina prsu hledá účastníky v lokalitách v Richmond a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Probíhá náborFáze 3
- Bon Secours Virginia Health System, Midlothian · Vzdálenost 11 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- a dalších 3
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Probíhá náborFáze 2
- Virginia Cancer Institute, Richmond
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Probíhá náborFáze 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · Vzdálenost 11 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Probíhá náborFáze 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · Vzdálenost 11 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Probíhá náborFáze 3
- Research Site, Midlothian · Vzdálenost 11 mi
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Probíhá náborFáze 3
- Clinical Trial Site, Midlothian · Vzdálenost 11 mi
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Probíhá nábor
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Probíhá náborFáze 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · Vzdálenost 6 mi
- Bon Secours St. Francis Medical Center, Midlothian · Vzdálenost 11 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Probíhá náborFáze 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Probíhá náborFáze 3
- Research Site, Midlothian · Vzdálenost 11 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Probíhá náborFáze 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- a dalších 4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Probíhá náborFáze 2/3
- Bon Secours St. Francis Medical Center, Midlothian · Vzdálenost 11 mi
E-Mindfulness Approaches for Living After Breast Cancer
Probíhá náborFáze 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- a dalších 4
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Probíhá nábor
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Probíhá náborFáze 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Probíhá náborFáze 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Probíhá náborFáze 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · Vzdálenost 11 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Probíhá náborFáze 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · Vzdálenost 6 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Probíhá náborFáze 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · Vzdálenost 6 mi
- a dalších 1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Probíhá náborObservační studie
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Probíhá náborObservační studie
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · Vzdálenost 11 mi
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Probíhá náborFáze 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Probíhá náborVítáni zdraví dobrovolníci
- Virginia Commonwealth University, Richmond
Studie Rakovina prsu v jiných městech
- New York City, NY134 studií
- Houston, TX126 studií
- Boston, MA111 studií
- Nashville, TN80 studií
- Los Angeles, CA72 studií
- Edison, NJ68 studií
- St. Louis, MO64 studií
- Durham, NC63 studií
- Queens, NY63 studií
- Chicago, IL58 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
Další studie v Richmond
- Nemalobuněčný plicní karcinom25 studií
- Rakovina prostaty19 studií
- Srdeční selhání16 studií
- Rakovina plic14 studií
- Kolorektální karcinom13 studií
- Kardiovaskulární onemocnění13 studií
- Steatotické onemocnění jater12 studií
- Akutní myeloidní leukemie12 studií
- Squamózní buněčný karcinom hlavy a krku12 studií
- Metastatický karcinom12 studií
- Melanom11 studií
- Obesity11 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.